INS and gestational diabetes: The failure of this intervention, and indeed many of the GDM lifestyle prevention trials, is possibly due to their initiation at a relatively late stage in the pregnancy (typically the second trimester) and not taking into account patient heterogeneity including variations in BMI and insulin resistance [31].